☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
generics
PhaseBio Reports First Patients Dosing in its P-III REVERSE-IT Study of Bentracimab in Canada
October 7, 2020
WHO Signs MoU with IGBA for Promoting the Access to Biosimilars and Generics
October 24, 2019
Load more...
Back to Home